AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
All Authorea-powered sites will be offline 6am-10am EDT Tuesday 11 June
for
Essential Maintenance
. We apologise for any inconvenience.
Samira Pourtaghi-Anvarian
Public Documents
1
Molnupiravir: A new candidate for COVID-19 treatment
Fariba Pourkarim
and 2 more
January 31, 2024
The novel coronavirus disease 2019 (COVID-19) emerged in late December 2019 in china and has rapidly spread to many countries around the world. The effective pharmacotherapy can reduce the mortality of COVID-19. Antiviral medications are the candidate therapies for the management of COVID-19. Molnupiravir is an antiviral drug with anti-RNA polymerase activity and currently is under investigation for the treatment of patients with COVID‐19. This review focuses on summarizing published literature for the mechanism of action of molnupiravir in COVID-19, safety, efficacy, and clinical trials of molnupiravir in the treatment of COVID‐19 patients.